|
TP53 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78697073699641E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.50950363320135E-11 |
| Normal-vs-Stage2 |
1.67289999630782E-08 |
| Normal-vs-Stage3 |
1.48649999975881E-07 |
| Normal-vs-Stage4 |
5.94019999999862E-05 |
| Stage1-vs-Stage2 |
2.738400E-01 |
| Stage1-vs-Stage3 |
7.624200E-01 |
| Stage1-vs-Stage4 |
9.090600E-01 |
| Stage2-vs-Stage3 |
2.775600E-01 |
| Stage2-vs-Stage4 |
5.010600E-01 |
| Stage3-vs-Stage4 |
7.753400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.03539399276542E-12 |
| Normal-vs-AfricanAmerican |
1.530110E-02 |
| Normal-vs-Asian |
3.22859999957181E-07 |
| Caucasian-vs-AfricanAmerican |
2.137400E-01 |
| Caucasian-vs-Asian |
6.914800E-01 |
| AfricanAmerican-vs-Asian |
1.870390E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80589987408553E-11 |
| Normal-vs-Female |
2.65319988201895E-11 |
| Male-vs-Female |
2.327600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19529941500218E-11 |
| Normal-vs-Age(41-60Yrs) |
1.16690002105457E-09 |
| Normal-vs-Age(61-80Yrs) |
1.04889999996693E-06 |
| Normal-vs-Age(81-100Yrs) |
1.457660E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.512600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.481200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.181400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.667600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.889400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.940400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.114800E-01 |
| Classical-VS-Follicular |
2.955800E-02 |
| Classical-VS-Other |
5.456800E-01 |
| Classical-VS-Normal |
1.74427139398858E-12 |
| Tall-VS-Follicular |
2.185400E-01 |
| Tall-VS-Other |
6.128000E-01 |
| Tall-VS-Normal |
2.974600E-04 |
| Follicular-VS-Other |
9.024200E-01 |
| Follicular-VS-Normal |
2.38059999999596E-05 |
| Other-VS-Normal |
1.288370E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.83639770057198E-11 |
| Normal-vs-N1 |
3.619900E-04 |
| N0-vs-N1 |
3.472600E-01 |
|
|
